Evidence map›Paper›PMID 37649932›Full record

ReviewCureus2023

Effects of Nondipping Blood Pressure Changes: A Nephrologist Prospect.

Elmukhtar Habas, Raza A Akbar, Gamal Alfitori, Khalifa L Farfar, Eshrak Habas, Nada Errayes, Aml Habas, Aisha Al Adab, Amnna Rayani, Nagat Geryo and 1 more

Open access · diamondAbstract readReview
In one paragraph

Review in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 4 countries.

Elmukhtar HabasInternal Medicine, Hamad General Hospital, Doha, QAT.
Raza A AkbarInternal Medicine, Hamad General Hospital, Doha, QAT.
Gamal AlfitoriInternal Medicine, Hamad General Hospital, Doha, QAT.
Khalifa L FarfarInternal Medicine, Alwakra General Hospital, Doha, QAT.
Eshrak HabasInternal Medicine, Tripoli University, Tripoli, LBY.
Nada ErrayesMedical Education, University of Lincoln, Lincoln, GBR.
Aml HabasRenal and Dialysis, Tripoli Pediatric Hospital, Tripoli, LBY.
Aisha Al AdabPulmonary Medicine, Hamad General Hospital, Doha, QAT.
Amnna RayaniHemato-Oncology, Tripoli Pediatric Hospital, Tripoli University, Tripoli, LBY.
Nagat GeryoInternal Medicine, Hamad General Hospital, Doha, QAT.
Abdel-Naser Y ElzoukiMedicine, Hamad General Hospital, Doha, QAT.
Hamad General Hospital · QAHamad Medical Corporation · QATripoli Central Hospital · LYLincoln Medical Center · USUniversity of Lincoln · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Blood pressure (BP) variations depend on various internal, environmental, and behavioral factors. BP fluctuations occur both in normotensive and hypertensive people. Although it fluctuates over the 24-hr day and night, the morning BP increases after waking up and declines throughout sleep. It is typical for BP to decrease by 10% to 20%, while sleeping, known as dipping BP. However, if there is no decrease in nighttime mean systolic BP or a drop of less than 10 mmHg, it is called nondipping BP. Conversely, reverse dipping BP means an increase in mean systolic BP instead of a drop during the night. Reverse dipping is observed in hypertension (HTN), diabetes mellitus (DM), chronic kidney disease (CKD), and obstructive sleep apnea (OSA) syndrome. The introduction of ambulatory BP monitoring (ABPM) led to the emergence of identifying normal and elevated BP patterns. Non-dipping BP increases the risk of cardiovascular system (CVS) complications such as left ventricular hypertrophy, proteinuria, glomerular filtration rate (GFR) reduction, and CKD progression. A loss or blunting of the normal BP profile is recognized as a deleterious variant, and restoring abnormal BP patterns has been reported to significantly impact end-organ damage, morbidity, and mortality. In this non-systematic clinically-oriented, comprehensive review, we aim to update the BP variables and the pathophysiology of nondipping BP and point out the areas which need more investigation from a nephrology perspective because the nondipping BP increases the risk of proteinuria, GFR reduction, and CKD progression. A literature search of PubMed, Google, EMBASE, and Google Scholar was conducted. Checks of selected papers and relevant reviews complemented the electronic search. With improved BP measurement methods, the physiology of BP profile variations is readily detectable during the day and night. A nondipping BP profile is a distinct BP pattern that may have significant end-organ damage effects and therapeutic importance for nephrologists. The pathophysiology of the nondipping BP variant must be clarified to prevent complications, and further investigations are required. Furthermore, there is debate about the best BP index to utilize: systolic BP, diastolic BP, mean arterial pressure, or a mixture of all. All these areas are important and need new research projects.

Indexed as

abnormal bp pattern-related mortalityaltered circadian bp rhythmambulatory blood pressure monitoringhtnkidney and nondipping bpnocturnal bp reverse dippingtarget organ damage

Identifiers

PMID37649932
PMCPMC10464654
OpenAlexW4385389737

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.